2018
DOI: 10.1016/j.amjcard.2017.12.033
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Selective Aspiration Thrombectomy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 21 publications
1
2
0
Order By: Relevance
“…Moreover, we found a small increase in the risk of in-hospital stroke, yet no evidence of a cumulative stroke risk at 180 days. These findings are generally consistent with previously published observational analyses of selective AT use, as well as randomized clinical trials of routine AT use adequately powered to examine clinical end points …”
Section: Discussionsupporting
confidence: 89%
“…Moreover, we found a small increase in the risk of in-hospital stroke, yet no evidence of a cumulative stroke risk at 180 days. These findings are generally consistent with previously published observational analyses of selective AT use, as well as randomized clinical trials of routine AT use adequately powered to examine clinical end points …”
Section: Discussionsupporting
confidence: 89%
“…Although several studies of the effectiveness of the selective use of TA have been published, selective TA performed based on the personal judgment of the operators was not associated with better outcomes [25]. Generally, TA appears to be beneficial in patients with a high thrombus burden.…”
Section: Discussionmentioning
confidence: 99%
“… 9 Recent prospective randomization clinical trials confirmed that TA improved myocardial perfusion but failed to improve the prognosis, possibly because of the short follow-up period. 8 While several studies indicated that TA during PPCI was not associated with a better clinical prognosis, 14 16 a meta-analysis reported that patients with a high thrombus burden received the highest potential benefit from TA. 17 This may explain why TA may be considered for a large residual thrombus burden in the 2017 European Society of Cardiology (ESC) guideline.…”
Section: Discussionmentioning
confidence: 99%